$Silo Pharma (SILO.US)$Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management 1 MINUTE AGO, 8:05 AM EST VIA GLOBENEWSWIRE Prototype development and feasibility testing underway for optimized subcutaneous delivery
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more